* OPKO Health Inc OPK.OQ reported a quarterly adjusted
loss of 9
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -11
cents. The mean expectation of six analysts for the quarter was
for a loss of 9 cents per share. Wall Street expected results to
range from -10 cents to -8 cents per share.
* Revenue fell 1.9% to $181.90 million from a year ago;
analysts
expected $177.53 million.
* OPKO Health Inc's reported EPS for the quarter was a loss
of 9
cents.
* The company reported a quarterly loss of $65.5 million.
* OPKO Health Inc shares had fallen by 34.0% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is "buy."
Wall Street's median 12-month price target for OPKO Health Inc
is $4.00
This summary was machine generated from LSEG data February 27 at
11:27 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.09 -0.09 Met
Sep. 30 2023 -0.10 -0.11 Missed
Jun. 30 2023 -0.07 -0.03 Beat
Mar. 31 2023 -0.08 -0.02 Beat